| Health / Medical Topics |
GVAX Lung Cancer Vaccine
An autologous lung cancer vaccine consisting of patient-specific lung cancer cells genetically modified to secrete granulocyte-macrophage colony stimulating factor (GM-CSF), an immunostimulatory cytokine. GM-CSF modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. This agent also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function and may augment host antitumoral immunity. For safety, cells are irradiated prior to vaccination. (NCI Thesaurus)
YOU MAY ALSO LIKE
GVAX cancer vaccines are autologous cell vaccines comprised of tumor cells which have been irradiated and genetically modified to secrete granulocyte-macrophage colony…
Antineoplastic vaccine being developed against liver cancer.
A country in northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.
A quassinoid phytochemical isolated from the plant Simaba guianensis with potential antineoplastic and antimalarial activities.
A type of smokeless tobacco that is made in India and is widely used throughout Asia. It is a mixture of tobacco,…
Non-encapsulated accumulations of lymphoid tissue in the alimentary tract that form a secretory immune system containing cells committed to IgA or IgE…
